Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):421-3

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

MINERVA OPINION EDITORIAL   

Minerva Urology and Nephrology 2021 August;73(4):421-3

DOI: 10.23736/S2724-6051.21.04525-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Senescence in prostate cancer: is there sufficient evidence to move forward?

Valerie CARPENTER 1, 2 , Riccardo AUTORINO 3, David A. GEWIRTZ 1, 2

1 School of Medicine, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; 2 Massey Cancer Center, Richmond, VA, USA; 3 Division of Urology, Department of Surgery, VCU Health, Richmond, VA, USA



inizio pagina